Rejuveron Life Sciences Company
Rejuveron Life Sciences AG is a biotechnology company that focuses on developing therapies and technologies to improve healthy aging and prolong lifespan. They are a team of drug discovery and development experts who are driven by curiosity about aging.
Investors
%20.jpg)
Estimated Revenue:
EUR 15.7 million
Funding Status:
Early Stage Venture
Industry:
Anti-aging Therapies
Investors Number:
11
Last Funding Date:
2022-03-17
Founded Date:
2019-01-01
Headquarters:
Schlieren, Zurich, Switzerland
Total Funding:
25102061
Last Funding Type:
Series B
Employee Number:
1-10